Market Update: Abbott Laboratories (NYSE:ABT) – Mylan To Acquire Abbott’s Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction

[PR Newswire] – PITTSBURGH, July 14, 2014 /PRNewswire/ — Mylan Inc. (MYL) today announced that it has entered into a definitive agreement with Abbott (ABT) whereby Mylan will acquire Abbott’s non-U.S. developed markets . . . → Read More: Market Update: Abbott Laboratories (NYSE:ABT) – Mylan To Acquire Abbott’s Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction Similar Articles: Company Update (NYSE:GE): Leading forensic laboratories participate in independent validation of the GE Healthcare Life Sciences and NetBio Rapid DNA system Company Update – McDonalds Corporation (NYSE:MCD) – McDonald’s global footprint: bringing obesity to both developed and emerging markets Stock market seasonality mid-year update